Atorvastatin DC Granules Manufacturer & Supplier
Atorvastatin granules designed for direct compression, balancing flow and compressibility to support low-dose statin tablets.
Product overview
Atorvastatin is a statin (HMG-CoA reductase inhibitor) used to lower LDL cholesterol and cardiovascular risk.
Pharmaceutical granules improve the flow and compressibility of an active ingredient so that tablet presses run with consistent weight and content uniformity.
Formulation and release profile
Direct compression (DC) granules are pre-granulated so they can be blended with excipients and compressed straight into tablets, removing the wet granulation, drying and milling steps.
Pharmaceutical applications
- Tablet manufacturing by direct compression for lipid-lowering products.
- Reducing in-house granulation steps and batch cycle time.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Atorvastatin DC Granules
- Form
- direct compression Granules
- Therapeutic category
- Cardiovascular
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Atorvastatin DC Granules to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all granules Manufacturing capabilities
Other Atorvastatin products from Rraynex
- Atorvastatin + Aspirin (WW) — Pellets
- Atorvastatin + Clopidogrel — Pellets
